VYVANSE 70 MG CAPSULE

lisdexamfetamine dimesylate
$12.3544per EA
High Outlier
DEA Schedule CII

Strength

70 mg/1

NDC

59417010710

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA021977

On Market Since

2/23/2007

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.2%

3Y

+4.6%

5Y

+15.3%

All

+106.4%